Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.

被引:0
|
作者
Kearney, A. Aileen [1 ]
Hill, L. [1 ]
Davidson, J. [1 ]
Mc Clure, C. [1 ]
Dixon, L. [1 ]
机构
[1] Royal Victoria Hosp, Belfast, Antrim, North Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1662
引用
收藏
页码:411 / 411
页数:1
相关论文
共 50 条
  • [21] SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION: REAL-WORLD EXPERIENCE FROM ITALY (THE REAL.IT STUDY)
    Di Lenarda, A.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Degli Esposti, L.
    D'Agostino, C.
    Peruzzi, E.
    Monopoli, S.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D134 - D134
  • [22] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)
    Di Lenarda, Andrea
    Di Gesaro, Gabriele
    Sarullo, Filippo Maria
    Miani, Daniela
    Driussi, Mauro
    Correale, Michele
    Bilato, Claudio
    Passantino, Andrea
    Carluccio, Erberto
    Villani, Alessandra
    degli Esposti, Luca
    d'Agostino, Chiara
    Peruzzi, Elena
    Poli, Simone
    Iacoviello, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [23] Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review
    Proudfoot, Clare
    Studer, Rachel
    Rajput, Tanvi
    Jindal, Ramandeep
    Agrawal, Rumjhum
    Corda, Stefano
    Senni, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 331 : 164 - 171
  • [24] Eligibility criteria for Sacubitril-Valsartan in patients admitted for heart failure: the real world
    David Cabrita Roque, D.
    Augusto, J.
    Santos, M.
    Candeias Faria, D.
    Baltazar Ferreira, J.
    Sacchetti, A.
    Melo, L.
    Oliveira Soares, A.
    Morais, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 477 - 478
  • [25] Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation
    Chang, Hung-Yu
    Feng, An-Ning
    Fong, Man-Cai
    Hsueh, Chao-Wen
    Lai, Wei-Tsung
    Huang, Kuan-Chih
    Chong, Eric
    Chen, Chi-Nan
    Chang, Hung-Chuan
    Yin, Wei-Hsian
    JOURNAL OF CARDIOLOGY, 2019, 74 (3-4) : 372 - 380
  • [26] Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension and dose titration
    Chang, H-Y Hung-Yu
    Hsieh, C-W
    Fong, M-C
    Feng, A-N
    Huang, K-C
    Lai, W-T
    Yin, W-H
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 416 - 416
  • [27] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
    Nordberg Backelin, Charlotte
    Fu, Michael
    Ljungman, Charlotta
    ESC HEART FAILURE, 2020, 7 (03): : 1049 - 1055
  • [28] Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on hypotension, titration and drug combination
    Chou, M. T. Ming-Ting
    Chen, S. Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 211 - 211
  • [29] The Impact of Sacubitril/Valsartan and ACEi/ARB on Renal Outcomes in Heart Failure: Evidence From Real World Clinical Practice
    Tan, Nicholas Y.
    Yao Xiaoxi
    Sangaralingham, Lindsey R.
    Shah, Nilay D.
    Rule, Andrew D.
    Burnett, John C.
    Dunlay, Shannon M.
    Sangaralingham, S. J.
    CIRCULATION, 2018, 138
  • [30] "Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
    Simpson, Joanne
    Benson, L.
    Jhund, P. S.
    Dahlstrom, U.
    McMurray, J. J. V.
    Lund, L. H.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (03) : 315 - 322